Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-22

Clinical Trial Update: suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sirolimus for superficial slow-flow vascular malformations has completed. The update provides the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: University Hospital, Tours | Conditions: Vascular Malformation | Phase 2 | Status: COMPLETED